APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,872,704 | -75.5% | 75,518 | -41.3% | 0.01% | -73.7% |
| Q2 2023 | $11,720,470 | +35.7% | 128,655 | -1.7% | 0.02% | +35.7% |
| Q1 2023 | $8,634,889 | +31.7% | 130,911 | +3.2% | 0.01% | +27.3% |
| Q4 2022 | $6,556,466 | -23.0% | 126,793 | +1.7% | 0.01% | -26.7% |
| Q3 2022 | $8,515,000 | +3447.9% | 124,671 | +2248.7% | 0.02% | – |
| Q2 2022 | $240,000 | -83.7% | 5,308 | -81.7% | 0.00% | -100.0% |
| Q1 2022 | $1,476,000 | +16.7% | 29,069 | +8.6% | 0.00% | +100.0% |
| Q4 2021 | $1,265,000 | – | 26,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
| Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
| SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
| Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
| HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
| CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
| Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
| Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
| Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
| Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |